| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Jun―15 |
A comprehensive analysis of diabetic patient data before and during the COVID-19 pandemic - Lessons from the MÉRY diabetes database (MDD) |
Zsolt Hermányi, Adrienn Menyhárt, Anna Erzsébet Körei, Ildikó Istenes, Genevieve Arany Lao-kan, Vanda Csiki, Abdallah Benhamida, Miklos Kozlovszky, Attila Berey, Peter Markovich, Péter Kempler |
| 2 |
[GO] |
2023―Apr―14 |
Increase in hypoglycaemia and hyperglycaemia in people with diabetes admitted to hospital during COVID-19 pandemic |
Yue Ruan, Luca Mercuri, Dimitri Papadimitriou, Algirdas Galdikas, Gail Roadknight, Jim Davies, Ben Glampson, Erik Mayer, Neil E. Hill, Rustam Rea |
| 3 |
[GO] |
2023―Jan―03 |
Metformin in SARS-CoV-2 infection: A hidden path - from altered inflammation to reduced mortality. A review from the literature |
Ana Realista Pedrosa, Diana Cruz Martins, Manfredi Rizzo, José Silva-Nunes |
| 4 |
[GO] |
2022―Dec―05 |
Type 1 diabetes outpatient care and treatment effectiveness during COVID-19: A single-center cohort study |
Michał Kania, Paulina Suduł, Konrad Mazur, Zlata Chaykivska, Mateusz Fiema, Marianna Kopka, Małgorzata Kostrzycka, Magdalena Wilk, Jerzy Hohendorff, Beata Kieć-Wilk, Tomasz Klupa, Przemysław Witek, Barbara Katra, Maciej T. Malecki |
| 5 |
[GO] |
2022―Nov―28 |
Effect of the first and second COVID-19 associated lockdown on the metabolic control of patients with type 2 diabetes in Greece |
Eleftheria Papachristoforou, Stavros Liatis, Ourania Psoma, Aikaterini Kountouri, Vaia Lambadiari, Vasilis Tsimihodimos |
| 6 |
[GO] |
2022―Nov―08 |
Access to care by medicare beneficiaries in the U.S. with diabetes and multiple chronic conditions during the COVID-19 pandemic |
John M. Clements |
| 7 |
[GO] |
2022―Aug―13 |
COVID-19-associated Mucormycosis: A clinico-epidemiological study |
Jaya Chakravarty, Munesh Kumar Gupta, Ragini Tilak, Rajesh kumar, Rajendra Prasad Maurya, Nilesh Kumar, Susheel Kumar Agarwal, Shiva S, Naresh Kumar Sharma, Neeraj Kumar Dhiman, Vishambhar Singh, Ashish verma, Tuhina Banerjee, Neeraj Kumar Agarwal, Ravi Shankar Prasad |
| 8 |
[GO] |
2022―Feb―07 |
Covid-19: A new cause of “provoked” A-β+ Ketosis-Prone Diabetes |
Ruchi Gaba, Ashok Balasubramanyam |
| 9 |
[GO] |
2022―Feb―04 |
Newly diagnosed diabetes vs. pre-existing diabetes upon admission for COVID-19: Associated factors, short-term outcomes, and long-term glycemic phenotypes |
Sara J. Cromer, Caitlin Colling, Daria Schatoff, Michael Leary, Maria I. Stamou, Daryl J. Selen, Melissa S. Putman, Deborah J. Wexler |
| 10 |
[GO] |
2021―Dec―09 |
Characterizing progressive beta-cell recovery after new-onset DKA in COVID-19 provoked A-β+ KPD (ketosis-prone diabetes): A prospective study from Eastern India |
Riddhi Das Gupta, Avica Atri, Sunetra Mondal, Abhishek Bhattacharjee, Ramprasad Garai, Arindam Kumar Hazra, Brojen Choudhury, Dhriti Sundar Dutta, Moushumi Lodh, Arunangshu Ganguly |
| 11 |
[GO] |
2021―Sep―28 |
Emotional burden and care of adults with type 1 diabetes during the COVID-19 pandemic in Brazilian regions |
Mônica S.V.M. Silveira, Elizabeth João Pavin, Edimariz Buin Cardoso, Paulo Fanti, Samereh Abdoli |
| 12 |
[GO] |
2021―May―28 |
Preadmission Predictors of Severe COVID-19 in Patients with Diabetes Mellitus |
Alpana P. Shukla, Beverly G. Tchang, Tiffany Lam, Ian Steller, I.I. Samir Touhamy, Gulce Askin, Felicia A. Mendelsohn Curanaj, Jane J. Seley, Daniel Lorber, Monika M. Safford, Louis J. Aronne, Laura C. Alonso |
| 13 |
[GO] |
2021―Apr―19 |
Pharmacological management of COVID-19 in Type 2 Diabetes |
Antonio Ceriello, Francesco Prattichizzo |
| 14 |
[GO] |
2021―Jan―20 |
Psychosocial health in people with diabetes during the first three months of the COVID-19 pandemic in Denmark |
Kristoffer Panduro Madsen, Ingrid Willaing, Naja Hulvej Rod, Tibor V. Varga, Lene Eide Joensen |
| 15 |
[GO] |
2020―Nov―26 |
Hyperglycemia associated with lymphopenia and disease severity of COVID-19 in type 2 diabetes mellitus |
Yangyang Cheng, Ling Yue, Zhiyang Wang, Junxia Zhang, Guangda Xiang |
| 16 |
[GO] |
2020―Nov―26 |
Impact of obesity on COVID-19 patients |
Wanqi Yu, Kristen E. Rohli, Shujuan Yang, Peng Jia |
| 17 |
[GO] |
2020―Oct―07 |
The Early Impact Of The COVID-19 Pandemic On Adults With Type 1 Or Type 2 Diabetes: A National Cohort Study |
Lawrence Fisher, William Polonsky, Adijat Asuni, Yasmin Jolly, Danielle Hessler |
| 18 |
[GO] |
2020―Oct―07 |
Effect of COVID-19-associated lockdown on the metabolic control of patients with type 2 diabetes |
Ourania Psoma, Eleftheria Papachristoforou, Aikaterini Kountouri, Kostantinos Balampanis, Athena Stergiou, Vaia Lambadiari, Stavros Liatis, Vasilis Tsimihodimos |
| 19 |
[GO] |
2020―Aug―26 |
Anti-inflammatory properties of antidiabetic drugs: a “promised land” in the COVID-19 era? |
Niki Katsiki, Ele Ferrannini |
| 20 |
[GO] |
2020―Jul―06 |
COVID-19 in people living with diabetes: An international consensus |
A.E. Caballero, A. Ceriello, A. Misra, P. Aschner, M.E. McDonnell, M. Hassanein, L. Ji, J.C. Mbanya, V.A. Fonseca |
| 21 |
[GO] |
2020―Jun―29 |
Clinical analysis of risk factors for severe COVID-19 patients with type 2 diabetes |
Qianhui Zhang, Yanhong Wei, Min Chen, Qianqian Wan, Xiaoqi Chen |
| 22 |
[GO] |
2020―May―22 |
COVID-19 and diabetes: The why, the what and the how |
Sarah Cuschieri, Stephan Grech |
| 23 |
[GO] |
2020―May―15 |
COVID-19 and diabetes: No time to drag our feet during an untimely pandemic |
Ioannis Kyrou, Tim Robbins, Harpal S. Randeva |
| 24 |
[GO] |
2020―May―14 |
Surgical treatment of diabetic foot ulcers during the COVID-19 pandemic in China |
Fenghua Tao, Xiaoyan Tang, Hai Tao, Yue Luo, Hui Cao, Wei Xiang, Yingchun Zhao, Lin Jin |
|
